Covered Stocks

Debjit Chattopadhyay

Work

Analyst Debjit Chattopadhyay works at GUGGENHEIM and is focused on the Healthcare sector with 77 price targets and ratings documented since 2014 spanning on 9 stocks. Previously, Debjit Chattopadhyay worked at JANNEY, ROTH. Analyst's average stock valuation to be materialised ratio is 44.79% with an average time for price targets to be met of 237.25 days.

Most recent stock forecast was given on SRPT, Sarepta Therapeutics, Inc at 03-Aug-2022.

Debjit Chattopadhyay best performing recommendations are on IONS (IONIS PHARMACEUTICALS, INC).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO, INC) at 12/9/2014. The price target of $58.29 was fulfilled within 3 days with a profit of $3.73 (6.84%) receiving and performance score of 22.79.

Average potential price target upside

QURE SRPT BEAM BLUE CLVS IONS NTLA TSHA PASG

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

57

$34.48 (153.11%)

2 months 12 days ago

0/2 (0%)

$32.36 (84.78%)

Buy

5 months 26 days ago

4/7 (57.14%)

$26.29 (66.75%)

893

Hold

24

$2.76 (12.99%)

56

5 months 26 days ago

3/4 (75%)

$9.62 (27.61%)

134

Buy

58

$35.82 (161.50%)

75

1 years 1 months 12 days ago

0/4 (0%)

$44.5 (187.06%)

Buy

1 years 7 months 21 days ago

2/2 (100%)

$8.27 (27.64%)

145

Show more analysts
QURE SRPT BEAM BLUE CLVS IONS NTLA TSHA PASG